Inspira Technologies Oxy BHN Ltd. (NASDAQ:IINN) sees strong growth in short-term interest


Inspira Technologies Oxy BHN Ltd (NASDAQ:IINNGet a rating) recorded a strong increase in short-term interest in the month of July. As of July 15, there was short interest totaling 361,400 shares, an increase of 3,514.0% from the June 30 total of 10,000 shares. Based on an average trading volume of 2,130,000 shares, the short interest ratio is currently 0.2 days. Currently, 4.5% of the stock’s shares are sold short.

Inspira Technologies Oxy BHN Stock Performance

Shares of Action Inspira Technologies Oxy BHN opened at $1.69 on Thursday. The company has a 50-day moving average of $1.69 and a 200-day moving average of $2.25. Inspira Technologies Oxy BHN has a 1 year minimum of $1.10 and a 1 year maximum of $9.59. The company has a quick ratio of 8.31, a current ratio of 8.31 and a leverage ratio of 0.06.

Institutional trading of Inspira Technologies Oxy BHN

An institutional investor recently bought a new position in Inspira Technologies Oxy BHN stock. Ieq Capital LLC bought a new position in shares of Inspira Technologies Oxy BHN Ltd. (NASDAQ:IINNGet a rating) in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 51,949 shares of the company, valued at approximately $134,000. Ieq Capital LLC held 0.67% of Inspira Technologies Oxy BHN at the end of the last quarter. 3.45% of the shares are currently held by institutional investors and hedge funds.

About Inspira Technologies Oxy BHN

(Get a rating)

Inspira Technologies Oxy BHN Ltd., a medical device company, engages in the research, development, manufacturing and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its flagship product is the Augmented Breathing Technology (ART) System, a respiratory support system comprising a portable, minimally invasive dual-lumen cannula, which is inserted into the jugular vein and uses direct extracorporeal blood oxygenation to elevate and stabilize declining oxygen saturation levels.

Read more



Get news and reviews for Inspira Technologies Oxy BHN Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Inspira Technologies Oxy BHN and related companies with MarketBeat.com’s FREE daily newsletter.